1-7 of 7
Umar Mahmood
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Non-invasive Detection of Immunotherapy-Induced Adverse Events

Carolina A. Ferreira, Pedram Heidari, Bahar Ataeinia, Nicoleta Sinevici, Meghan E. Sise, Robert B. Colvin, Eric Wehrenberg-Klee, Umar Mahmood
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (19): 5353–5364.
https://doi.org/10.1158/1078-0432.CCR-20-4641
Published: 01 October 2021
View article titled, Non-invasive Detection of Immunotherapy-Induced Adverse Events
Open the PDF for Non-invasive Detection of Immunotherapy-Induced Adverse Events in another window
Includes: Supplementary data
Journal Articles

The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging

Benjamin M. Larimer, Emily Bloch, Sarah Nesti, Emily E. Austin, Eric Wehrenberg-Klee, Genevieve Boland, Umar Mahmood
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1196–1205.
https://doi.org/10.1158/1078-0432.CCR-18-2407
Published: 15 February 2019
View article titled, The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging
Open the PDF for The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging in another window
Includes: Supplementary data
Journal Articles

Correction: 18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials

Yingbing Wang, Karen L. Ayres, Debra A. Goldman, Maura N. Dickler, Aditya Bardia, Ingrid A. Mayer, Eric Winer, Jill Fredrickson, Carlos L. Arteaga, José Baselga, Henry C. Manning, Umar Mahmood, Gary A. Ulaner
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1435.
https://doi.org/10.1158/1078-0432.CCR-18-4266
Published: 15 February 2019
View article titled, Correction: <sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Open the PDF for Correction: <sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials in another window
Journal Articles

18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials

Yingbing Wang, Karen L. Ayres, Debra A. Goldman, Maura N. Dickler, Aditya Bardia, Ingrid A. Mayer, Eric Winer, Jill Fredrickson, Carlos L. Arteaga, José Baselga, Henry C. Manning, Umar Mahmood, Gary A. Ulaner
Journal: Clinical Cancer Research
Clin Cancer Res (2017) 23 (12): 3053–3060.
https://doi.org/10.1158/1078-0432.CCR-16-2197
Published: 14 June 2017
View article titled, <sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials
Open the PDF for <sup>18</sup>F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials in another window
Journal Articles

Pharmacodynamic Imaging Guides Dosing of a Selective Estrogen Receptor Degrader

Pedram Heidari, Francis Deng, Shadi A. Esfahani, Alicia K. Leece, Timothy M. Shoup, Neil Vasdev, Umar Mahmood
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (6): 1340–1347.
https://doi.org/10.1158/1078-0432.CCR-14-1178
Published: 12 March 2015
View article titled, Pharmacodynamic Imaging Guides Dosing of a Selective Estrogen Receptor Degrader
Open the PDF for Pharmacodynamic Imaging Guides Dosing of a Selective Estrogen Receptor Degrader in another window
Journal Articles

Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation

Eric S. Martin, Peter J. Belmont, Mark J. Sinnamon, Larissa Georgeon Richard, Jing Yuan, Erin M. Coffee, Jatin Roper, Lydia Lee, Pedram Heidari, Sophia Y. Lunt, Gautam Goel, Xiadong Ji, Zhi Xie, Tao Xie, John Lamb, Scott L. Weinrich, Todd VanArsdale, Roderick T. Bronson, Ramnik J. Xavier, Matthew G. Vander Heiden, Julie L. C. Kan, Umar Mahmood, Kenneth E. Hung
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 2929–2940.
https://doi.org/10.1158/1078-0432.CCR-12-2307
Published: 30 May 2013
View article titled, Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation
Open the PDF for Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation in another window
Includes: Supplementary data
Journal Articles

Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin

Geoffrey D. Girnun, Liang Chen, Jessica Silvaggi, Ronny Drapkin, Lucian R. Chirieac, Robert F. Padera, Rabi Upadhyay, Scott B. Vafai, Ralph Weissleder, Umar Mahmood, Elnaz Naseri, Stephanie Buckley, Danan Li, Jeremy Force, Kate McNamara, George Demetri, Bruce M. Spiegelman, Kwok-Kin Wong
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6478–6486.
https://doi.org/10.1158/1078-0432.CCR-08-1128
Published: 16 October 2008
View article titled, Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin
Open the PDF for Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin in another window